SLFN5

Across TCGA pan-cancer cohorts, SLFN5 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated SLFN5 data layer compared with 22 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SLFN5 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated SLFN5 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LUSC show a favorable association.

UCEC, ESCA, and SCLC are the cancer types where SLFN5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.968	0.615	.004	12	view →
ESCA	OS	Median	II,III,IV	0.216	0.702	.014	6	view →
SCLC	OS	Median	All	0.219	0.650	.031	3	view →
COAD	OS	Median	All	0.539	0.875	.006	1	view →
LUSC	DFS	Median	All	1.000	0.654	.047	1	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SLFN5–UCEC (DFS)

Open the UCEC breakdown →